SARS-COV-2, Letrozole, VaccinesMay 11, 2020 | Oncology Allergy & Immunology Interpreting Diagnostic Tests for SARS‑CoV‑2 This JAMA “Viewpoint” describes how to interpret two types of diagnostic tests commonly in use for SARS-CoV-2 infections—reverse transcriptase–polymerase chain reaction (RT-PCR) and IgM and IgG enzyme-linked immunosorbent assay (ELISA)—and how the results may vary over time. Read full article Internal Medicine Letrozole Pre-Surgery Yields Drastic Biomarker Changes in ER+ DCIS According to a study featured in the Journal of Clinical Oncology, pre-surgery letrozole led to significant imaging and biomarker changes in postmenopausal patients with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS) in a phase 2 clinical trial. Read full article Allergy & Immunology COVID-19: US Scientists Identify 14 Vaccines to Focus On This roundup of articles highlights the 14 vaccines doctors are targeting in the fight against COVID‑19, in addition to featuring one doctor’s claim that the virus was active in France in December 2019, almost a month earlier than previously believed. Read full article
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH